155 related articles for article (PubMed ID: 27104669)
21. Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine.
Qian L; Chen K; Wang C; Chen Z; Meng Z; Wang P
Clin Cancer Res; 2020 Jul; 26(13):3408-3419. PubMed ID: 32156748
[TBL] [Abstract][Full Text] [Related]
22. Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma.
Reyes-Uribe P; Adrianzen-Ruesta MP; Deng Z; Echevarria-Vargas I; Mender I; Saheb S; Liu Q; Altieri DC; Murphy ME; Shay JW; Lieberman PM; Villanueva J
Oncogene; 2018 Jul; 37(30):4058-4072. PubMed ID: 29695835
[TBL] [Abstract][Full Text] [Related]
23. α-Mangostin induces apoptosis in human chondrosarcoma cells through downregulation of ERK/JNK and Akt signaling pathway.
Krajarng A; Nakamura Y; Suksamrarn S; Watanapokasin R
J Agric Food Chem; 2011 May; 59(10):5746-54. PubMed ID: 21446759
[TBL] [Abstract][Full Text] [Related]
24. NRAS
Banik I; Cheng PF; Dooley CM; Travnickova J; Merteroglu M; Dummer R; Patton EE; Busch-Nentwich EM; Levesque MP
Pigment Cell Melanoma Res; 2021 Mar; 34(2):150-162. PubMed ID: 32910840
[TBL] [Abstract][Full Text] [Related]
25. Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells.
Vujic I; Sanlorenzo M; Esteve-Puig R; Vujic M; Kwong A; Tsumura A; Murphy R; Moy A; Posch C; Monshi B; Rappersberger K; Ortiz-Urda S
Oncotarget; 2016 Feb; 7(6):7297-306. PubMed ID: 26771141
[TBL] [Abstract][Full Text] [Related]
26. Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells.
Posch C; Sanlorenzo M; Vujic I; Oses-Prieto JA; Cholewa BD; Kim ST; Ma J; Lai K; Zekhtser M; Esteve-Puig R; Green G; Chand S; Burlingame AL; Panzer-Grümayer R; Rappersberger K; Ortiz-Urda S
J Invest Dermatol; 2016 Oct; 136(10):2041-2048. PubMed ID: 27251789
[TBL] [Abstract][Full Text] [Related]
27. Treatment of NRAS-mutant melanoma.
Johnson DB; Puzanov I
Curr Treat Options Oncol; 2015 Apr; 16(4):15. PubMed ID: 25796376
[TBL] [Abstract][Full Text] [Related]
28. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
[TBL] [Abstract][Full Text] [Related]
29. HSP70 inhibition blocks adaptive resistance and synergizes with MEK inhibition for the treatment of NRAS-mutant melanoma.
Parris JLD; Barnoud T; Leu JI; Leung JC; Ma W; Kirven NA; Poli ANR; Kossenkov AV; Liu Q; Salvino JM; George DL; Weeraratna AT; Chen Q; Murphy ME
Cancer Res Commun; 2021 Oct; 1(1):17-29. PubMed ID: 35187538
[TBL] [Abstract][Full Text] [Related]
30. Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib.
Krayem M; Journe F; Wiedig M; Morandini R; Sales F; Awada A; Ghanem G
Eur J Cancer; 2014 May; 50(7):1310-20. PubMed ID: 24559688
[TBL] [Abstract][Full Text] [Related]
31. MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients.
Kirchberger MC; Ugurel S; Mangana J; Heppt MV; Eigentler TK; Berking C; Schadendorf D; Schuler G; Dummer R; Heinzerling L
Eur J Cancer; 2018 Jul; 98():10-16. PubMed ID: 29843107
[TBL] [Abstract][Full Text] [Related]
32. Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer.
Queralt B; Cuyàs E; Bosch-Barrera J; Massaguer A; de Llorens R; Martin-Castillo B; Brunet J; Salazar R; Menendez JA
Oncotarget; 2016 Dec; 7(50):82185-82199. PubMed ID: 27636997
[TBL] [Abstract][Full Text] [Related]
33. MEK inhibitors for the treatment of NRAS mutant melanoma.
Sarkisian S; Davar D
Drug Des Devel Ther; 2018; 12():2553-2565. PubMed ID: 30154648
[TBL] [Abstract][Full Text] [Related]
34. COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.
Botti G; Fratangelo F; Cerrone M; Liguori G; Cantile M; Anniciello AM; Scala S; D'Alterio C; Trimarco C; Ianaro A; Cirino G; Caracò C; Colombino M; Palmieri G; Pepe S; Ascierto PA; Sabbatino F; Scognamiglio G
J Transl Med; 2017 Feb; 15(1):46. PubMed ID: 28231855
[TBL] [Abstract][Full Text] [Related]
35. NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.
Kießling MK; Nicolay JP; Schlör T; Klemke CD; Süss D; Krammer PH; Gülow K
Oncotarget; 2017 Jul; 8(28):45687-45697. PubMed ID: 28537899
[TBL] [Abstract][Full Text] [Related]
36. Beta-mangostin from Cratoxylum arborescens activates the intrinsic apoptosis pathway through reactive oxygen species with downregulation of the HSP70 gene in the HL60 cells associated with a G
Omer FAA; Hashim NBM; Ibrahim MY; Dehghan F; Yahayu M; Karimian H; Salim LZA; Mohan S
Tumour Biol; 2017 Nov; 39(11):1010428317731451. PubMed ID: 29110583
[TBL] [Abstract][Full Text] [Related]
37. Isoegomaketone induces apoptosis in SK-MEL-2 human melanoma cells through mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
Kwon SJ; Lee JH; Moon KD; Jeong IY; Yee ST; Lee MK; Seo KI
Int J Oncol; 2014 Nov; 45(5):1969-76. PubMed ID: 25119993
[TBL] [Abstract][Full Text] [Related]
38. α-Mangostin induces mitochondrial dependent apoptosis in human hepatoma SK-Hep-1 cells through inhibition of p38 MAPK pathway.
Hsieh SC; Huang MH; Cheng CW; Hung JH; Yang SF; Hsieh YH
Apoptosis; 2013 Dec; 18(12):1548-60. PubMed ID: 23912717
[TBL] [Abstract][Full Text] [Related]
39. α-Mangostin Induces Apoptosis in Human Osteosarcoma Cells Through ROS-Mediated Endoplasmic Reticulum Stress via the WNT Pathway.
Yang S; Zhou F; Dong Y; Ren F
Cell Transplant; 2021; 30():9636897211035080. PubMed ID: 34318699
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of autophagy augments the anticancer activity of α-mangostin in chronic myeloid leukemia cells.
Chen JJ; Long ZJ; Xu DF; Xiao RZ; Liu LL; Xu ZF; Qiu SX; Lin DJ; Liu Q
Leuk Lymphoma; 2014 Mar; 55(3):628-38. PubMed ID: 23734655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
